Douglas B. Snyder, Chief Legal Officer at GW PHARMACEUTICALS PLC (GWPH), sold 41,424 shares at $11.11 ($456K) on 2020-12-07, disclosed to the SEC on 2020-12-09.
Open-market sale of $456k GWPH by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.84 | 4,800 | $52K | 11.4% |
| 2 | $10.95 | 9,444 | $103K | 22.7% |
| 3 | $10.95 | 9,444 | $103K | 22.7% |
| 4 | $11.02 | 3,984 | $44K | 9.6% |
| 5 | $11.11 | 5,076 | $56K | 12.4% |
| 6 | $11.11 | 5,076 |
| $56K |
| 12.4% |
| 7 | $11.19 | 1,200 | $13K | 2.9% |
| 8 | $11.30 | 2,400 | $27K | 5.9% |
| Total | $11.01 avg | 41,424 | $456K | 100% |
| Filing → |
| GWPH | SELL | 2020-08-12 | $226K | — | Filing → |
| GWPH | SELL | 2020-07-08 | $103K | — | Filing → |
| GWPH | SELL | 2020-03-04 | $21K | — | Filing → |